Search for: "Johnson v. Directv, Inc." Results 1 - 20 of 21
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jan 2016, 8:58 am by Ad Law Defense
Italian Colors Restaurant, 133 S.Ct. 2304 (2013) and DIRECTV, Inc. v. [read post]
13 Sep 2010, 3:12 pm by Gareth
(Tiffany (NJ), Inc. v. eBay, Inc.,  600 F.3d 112, quoting Time Warner Cable, Inc. v. [read post]
6 May 2019, 7:53 am by Rebecca Tushnet
Rebecca Tushnet, Harvard Law School, On PufferyPuffery is a concept that purports to be about things consumers ignore and don’t rely on. [read post]
13 Mar 2015, 10:47 am by John Elwood
And in DIRECTV v. [read post]
28 Apr 2008, 12:00 pm
Johnson & Son, Inc. and the Council on Foreign Relations. [read post]
27 Feb 2009, 7:00 am
– Address to Joint Session of Congress 24 Feb (Securing Innovation) (Securing Innovation)   US Patents – Decisions Supreme Court rejects Federal Trade Commission’s bid to revive battle with Rambus (Law360) (ContentAgenda) (Hal Wegner) Supreme Court declines petition to review Singleton v Volkswagon regarding transfer of venue under 28 USC §1404(a) (Patent Prospector) (Hal Wegner) CAFC: Affidavit evidence to rebut KSR obviousness: Pivonka… [read post]
13 Oct 2008, 12:12 pm
ECJ clarifies rules relating to notice: K-Swiss Inc v OHIM (Class 46) EU Competitiveness Council resolution against counterfeiting and piracy (Class 46) EU states back three-point anti-piracy plan (Managing Intellectual Property) Fuel cells and wind power lead European patent filings for clean energy technology (Green Patent Blog) More non-minor geographical indicator (GI) amendments published (Class 46) No sign of any Community patent progress, despite Verheugen's optimism… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]